Beijing Kewei Clinical Diagnostic Reagent Inc. specializes in the development and production of various diagnostic technologies, including rapid tests, CLIA (Chemiluminescent Immunoassay), ELISA (Enzyme-Linked Immunosorbent Assay), and RT-PCR (Reverse Transcription Polymerase Chain Reaction). These technologies are designed to provide accurate and timely diagnostic results, facilitating effective disease management and patient care. The company emphasizes innovation and creativity in its product offerings, ensuring that they meet the evolving needs of healthcare providers and patients.

In addition to its core diagnostic products, Beijing Kewei also offers a Point-of-Care Testing (POCT) Analyser System, which allows for immediate testing and results at the site of patient care. This system enhances the efficiency of clinical diagnostics by reducing the time between sample collection and result reporting. The company is committed to providing comprehensive support, including technical assistance and OEM services, to its partners and distributors, further solidifying its role as a key player in the clinical diagnostic industry.

China

Kewei's products include the diagnostic kits of hepatitis B surface antigen, hepatitis B surface antibody, hepatitis B 'e' antigen, hepatitis B 'e' antibody and hepatitis B core antibody, hepatitis a virus IgM diagnostic kits, hepatitis E virus IgM diagnostic kits, RPR diagnostic kits, HBV test cassettes, HIV Ag/Ab diagnostic kits, etc.

Beijing Kewei Clinical Diagnostic Reagent

Company Details